These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27896954)
21. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856 [TBL] [Abstract][Full Text] [Related]
22. Mealtime Insulin Dosing by Carbohydrate Counting in Hospitalized Cardiology Patients: A Retrospective Cohort Study. Thurber KM; Dierkhising RA; Reiland SA; Pearson KK; Smith SA; O'Meara JG Diabetes Technol Ther; 2016 Jan; 18(1):15-21. PubMed ID: 26230278 [TBL] [Abstract][Full Text] [Related]
23. Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes. Mathiesen JM; Secher AL; Ringholm L; Nørgaard K; Hommel E; Andersen HU; Damm P; Mathiesen ER J Matern Fetal Neonatal Med; 2014 May; 27(7):724-8. PubMed ID: 23981186 [TBL] [Abstract][Full Text] [Related]
24. Continuous Glucose Monitoring and Bolus Calculators: A Good Combination. Heinemann L; Thomas A J Diabetes Sci Technol; 2024 Jul; 18(4):761-763. PubMed ID: 37804180 [No Abstract] [Full Text] [Related]
25. Accuracy of Automatic Carbohydrate, Protein, Fat and Calorie Counting Based on Voice Descriptions of Meals in People with Type 1 Diabetes. Ladyzynski P; Krzymien J; Foltynski P; Rachuta M; Bonalska B Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690520 [TBL] [Abstract][Full Text] [Related]
26. Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy. Kordonouri O; Hartmann R; Remus K; Bläsig S; Sadeghian E; Danne T Pediatr Diabetes; 2012 Nov; 13(7):540-4. PubMed ID: 22765260 [TBL] [Abstract][Full Text] [Related]
28. Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes. Cukierman-Yaffe T; Konvalina N; Cohen O Diabetes Res Clin Pract; 2011 Apr; 92(1):69-73. PubMed ID: 21292340 [TBL] [Abstract][Full Text] [Related]
29. The education of patients in prandial insulin dosing related to the structure of bolus calculators. Błazik M; Pańkowska E Pediatr Endocrinol Diabetes Metab; 2010; 16(4):301-5. PubMed ID: 21447273 [TBL] [Abstract][Full Text] [Related]
30. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes. Alemzadeh R; Parton EA; Holzum MK Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060 [TBL] [Abstract][Full Text] [Related]
31. Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy. Traina AN; Lull ME; Hui AC; Zahorian TM; Lyons-Patterson J Can J Diabetes; 2014 Aug; 38(4):269-72. PubMed ID: 24797495 [TBL] [Abstract][Full Text] [Related]
32. A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. Gross TM; Kayne D; King A; Rother C; Juth S Diabetes Technol Ther; 2003; 5(3):365-9. PubMed ID: 12828818 [TBL] [Abstract][Full Text] [Related]
33. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study. Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385 [TBL] [Abstract][Full Text] [Related]
34. Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment. Kapellen TM; Heidtmann B; Lilienthal E; Rami-Merhar B; Engler-Schmidt C; Holl RW Diabetes Technol Ther; 2015 Dec; 17(12):872-9. PubMed ID: 26509360 [TBL] [Abstract][Full Text] [Related]
35. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective. Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389 [TBL] [Abstract][Full Text] [Related]
36. [Continuous subcutaneous insulin infusion in type 1 diabetic during pregnancy: case report and literature review]. Reis JS; Lamounier RN; Menezes PA; Calsolari MR; Purisch S Arq Bras Endocrinol Metabol; 2008 Jun; 52(4):697-700. PubMed ID: 18604384 [TBL] [Abstract][Full Text] [Related]
37. Type 1 Diabetes and Long-Term Continuous Subcutaneous Insulin Infusion Therapy: A 10-Year Experience from Macedonia. Petrovski G; Zivkovic M; Stratrova SS; Todorova BJ Diabetes Technol Ther; 2017 Dec; 19(12):739-743. PubMed ID: 28976785 [TBL] [Abstract][Full Text] [Related]
38. Continuous subcutaneous insulin infusion (CSII) pumps. Valla V Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693 [TBL] [Abstract][Full Text] [Related]
39. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Pozzilli P; Battelino T; Danne T; Hovorka R; Jarosz-Chobot P; Renard E Diabetes Metab Res Rev; 2016 Jan; 32(1):21-39. PubMed ID: 25865292 [TBL] [Abstract][Full Text] [Related]